These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 11826099)

  • 1. Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau.
    Klein C; Kramer EM; Cardine AM; Schraven B; Brandt R; Trotter J
    J Neurosci; 2002 Feb; 22(3):698-707. PubMed ID: 11826099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Process elongation of oligodendrocytes is promoted by the Kelch-related actin-binding protein Mayven.
    Jiang S; Avraham HK; Park SY; Kim TA; Bu X; Seng S; Avraham S
    J Neurochem; 2005 Mar; 92(5):1191-203. PubMed ID: 15715669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of the microtubule associated protein tau impairs process outgrowth and myelin basic protein mRNA transport in oligodendrocytes.
    Seiberlich V; Bauer NG; Schwarz L; Ffrench-Constant C; Goldbaum O; Richter-Landsberg C
    Glia; 2015 Sep; 63(9):1621-35. PubMed ID: 25847153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fyn kinase is involved in oligodendroglial cell differentiation induced by apotransferrin.
    Perez MJ; Ortiz EH; Roffé M; Soto EF; Pasquini JM
    J Neurosci Res; 2009 Nov; 87(15):3378-89. PubMed ID: 19115405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination.
    Krämer EM; Klein C; Koch T; Boytinck M; Trotter J
    J Biol Chem; 1999 Oct; 274(41):29042-9. PubMed ID: 10506155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.
    Belkadi A; LoPresti P
    J Neurochem; 2008 Oct; 107(2):351-60. PubMed ID: 18680553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendrocyte differentiation and signaling after transferrin internalization: a mechanism of action.
    Pérez MJ; Fernandez N; Pasquini JM
    Exp Neurol; 2013 Oct; 248():262-74. PubMed ID: 23797152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau.
    Usardi A; Pooler AM; Seereeram A; Reynolds CH; Derkinderen P; Anderton B; Hanger DP; Noble W; Williamson R
    FEBS J; 2011 Aug; 278(16):2927-37. PubMed ID: 21692989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proline substitutions and threonine pseudophosphorylation of the SH3 ligand of 18.5-kDa myelin basic protein decrease its affinity for the Fyn-SH3 domain and alter process development and protein localization in oligodendrocytes.
    Smith GS; De Avila M; Paez PM; Spreuer V; Wills MK; Jones N; Boggs JM; Harauz G
    J Neurosci Res; 2012 Jan; 90(1):28-47. PubMed ID: 21887699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netrin 1 and Dcc regulate oligodendrocyte process branching and membrane extension via Fyn and RhoA.
    Rajasekharan S; Baker KA; Horn KE; Jarjour AA; Antel JP; Kennedy TE
    Development; 2009 Feb; 136(3):415-26. PubMed ID: 19141671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAP couples Fyn to SLAM immune receptors.
    Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
    Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
    Noack M; Leyk J; Richter-Landsberg C
    Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau interacts with src-family non-receptor tyrosine kinases.
    Lee G; Newman ST; Gard DL; Band H; Panchamoorthy G
    J Cell Sci; 1998 Nov; 111 ( Pt 21)():3167-77. PubMed ID: 9763511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-related modifications in tau affect the interaction between Fyn and Tau.
    Bhaskar K; Yen SH; Lee G
    J Biol Chem; 2005 Oct; 280(42):35119-25. PubMed ID: 16115884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.
    Arold S; Franken P; Strub MP; Hoh F; Benichou S; Benarous R; Dumas C
    Structure; 1997 Oct; 5(10):1361-72. PubMed ID: 9351809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.
    LoPresti P
    Neurochem Res; 2015 Nov; 40(11):2188-99. PubMed ID: 26394614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fyn tyrosine kinase regulates oligodendroglial cell development but is not required for morphological differentiation of oligodendrocytes.
    Sperber BR; McMorris FA
    J Neurosci Res; 2001 Feb; 63(4):303-12. PubMed ID: 11170180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodendroglial p130Cas is a target of Fyn kinase involved in process formation, cell migration and survival.
    Gonsior C; Binamé F; Frühbeis C; Bauer NM; Hoch-Kraft P; Luhmann HJ; Trotter J; White R
    PLoS One; 2014; 9(2):e89423. PubMed ID: 24586768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase.
    Osterhout DJ; Wolven A; Wolf RM; Resh MD; Chao MV
    J Cell Biol; 1999 Jun; 145(6):1209-18. PubMed ID: 10366594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.